Kirtenkumar Patel

Kirtenkumar Patel

Auto-generated profile, based on publicly available information

Kirtenkumar Patel

Department of Cardiology North Shore University Hospital Manhasset NY USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 March 2021 in The American Journal of Cardiology
Verified
Journal Article
Closed access
STSamarthkumar Thakkar
Samarthkumar Thakkar
HPHarsh P. Patel
Harsh P. Patel
MCMedhat Chowdhury
Medhat Chowdhury
KPKirtenkumar Patel
Kirtenkumar Patel
AKAshish Kumar
Ashish Kumar
ADAbhishek Deshmukh
Abhishek Deshmukh

22 June 2021 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
MKMuhammad Zubair Khan
Muhammad Zubair Khan
KPKirtenkumar Patel
Kirtenkumar Patel
MZMuhammad Samsoor Zarak
Muhammad Samsoor Zarak
AGAshwani Gupta
Ashwani Gupta
IHIshtiaq Hussian
Ishtiaq Hussian
SKSteven Kutalek
Steven Kutalek
Background: The association between atrial fibrillation (Afib) and sinus and AV nodal dysfunction has previously been reported. However, no data are available regarding the association between Afib and bundle branch block (BBB).Methods: Patient data were obtained from the Nationwide Inpatient Sample (NIS) database between years 2009 and 2015. Patients with a diagnosis of Afib and BBB were identified using validated International Classification of Diseases, 9th revision, and Clinical Modification (ICD‐9‐CM) codes. Statistical analysis using the chi‐square test and multivariate linear regression analysis were performed to determine the association between Afib and BBB.Results: The total number of patients with BBB was 3,116,204 (1.5%). Patients with BBB had a mean age of 73.5 ± 13.5 years, 53.6% were males, 39.1% belonged to the age group ≥80 years, and 72.9% were Caucasians. The prevalence of Afib was higher in the BBB group, as compared to the non‐BBB group (29% vs 11.8%, p value<.001). This association remained significant in multivariate regression analysis with an odds ratio of 1.25 (CI: 1.24‐1.25, P < .001). Among the subtypes of BBB, Afib was comparatively more associated with RBBB (1.32, CI 1.31‐1.33, p value<.0001) than LBBB (1.17, CI 1.16‐1.18, p value<.0001). The mean cost was higher among Afib with BBB, compared with Afib patients without BBB ($15 795 vs $14 391, p value<.0001). There was no significant difference in the mean length of stay (5.6 vs 5.9 days, p value<.0001) or inpatient mortality (4.9% vs 4.8%).Conclusion: This study demonstrates that prevalence of Afib is higher in patients with BBB than without BBB. Cost are higher for Afib patients with BBB, compared to those without BBB, with no significant increase in mortality or length of stay.

7 July 2021 in Journal of Arrhythmia
Verified
Journal Article
Open access
PDF file
MKMuhammad Zubair Khan
Muhammad Zubair Khan
AGAshwani Gupta
Ashwani Gupta
JHJordesha Hodge
Jordesha Hodge
KPKirtenkumar Patel
Kirtenkumar Patel
KPKrunalkumar Patel
Krunalkumar Patel
SKSteven Kutalek
Steven Kutalek
Background: Atrial fibrillation (Afib) is a common cardiac manifestation of hyperthyroidism. The data regarding outcomes of Afib with and without hyperthyroidism are lacking.Hypothesis: We hypothesized that patients with Afib and hyperthyroidism have better clinical outcomes, compared with Afib patients without hyperthyroidism.Methods: We queried the National Inpatient Sample database for years 2015‐2017 using Validated ICD‐10‐CM codes for Afib and hyperthyroidism. Patients were separated into two groups, Afib with hyperthyroidism and without hyperthyroidism.Results: The study was conducted with 68 095 278 patients. A total of 9 727 295 Afib patients were identified, 90 635 (0.9%) had hyperthyroidism. The prevalence of hyperthyroidism was higher in patients with Afib (0.9% vs 0.4%, P < .001), compared with patients without Afib. Using multivariate regression analysis adjusting for various confounding factors, the odds ratio of Afib with hyperthyroidism was 2.08 (CI 2.07‐2.10; P < .0001). Afib patients with hyperthyroidism were younger (71 vs 75 years, P < .0001) and more likely to be female (64% vs 47%; P < .0001) as compared with Afib patients without hyperthyroidism. Afib patients with hyperthyroidism had lower prevalence of CAD (36% vs 44%, P < .0001), cardiomyopathy (24.1% vs 25.9%, P < .0001), valvular disease (6.9% vs 7.4%, P < .0001), hypertension (60.7% vs 64.4%, P < .0001), diabetes mellitus (29% vs 32%, P < .0001) and obstructive sleep apnea (10.5% vs 12.2%, P < .0001). Afib with hyperthyroidism had lower hospitalization cost ($14 968 ± 21 871 vs $15 955 ± 22 233, P < .0001), shorter mean length of stay (5.7 ± 6.6 vs 5.9 ± 6.6 days, P < .0001) and lower in‐hospital mortality (3.3% vs 4.8%, P < .0001. The disposition to home was higher in Afib with hyperthyroidism patients (51% vs 42; P < .0001).Conclusion: Hyperthyroidism is associated with Afib in both univariate and multivariate analysis. Afib patients with hyperthyroidism have better clinical outcomes, compared with Afib patients without hyperthyroidism.

1 May 2021 in JACC
Verified
Journal Article
Closed access
STSamarthkumar Thakkar
Samarthkumar Thakkar
HPHarsh Patel
Harsh Patel
BTBryan E-Xin Tan
Bryan E-Xin Tan
SPSmit Patel
Smit Patel
KPKirtenkumar Patel
Kirtenkumar Patel
SPSidakpal Panaich
Sidakpal Panaich

1 May 2021 in JACC
Verified
Journal Article
Closed access
KPKrunalkumar Patel
Krunalkumar Patel
KPKirtenkumar Patel
Kirtenkumar Patel
MKMuhammad Zubair Khan
Muhammad Zubair Khan
HPHarsh Patel
Harsh Patel
APAmitkumar Patel
Amitkumar Patel
VFVincent Figueredo
Vincent Figueredo

1 May 2021 in JACC
Verified
Journal Article
Closed access
JSJay Shah
Jay Shah
KLKritika Luthra
Kritika Luthra
SASindhu Avula
Sindhu Avula
MDMa'EN Al Dabbas
Ma'EN Al Dabbas
KPKrunalkumar Patel
Krunalkumar Patel
SASyed Ali
Syed Ali